SCHEMBL1127124

SCHEMBL1127124

C=CCN(C(=O)O)c1cccc(-c2nc(N3CCOCC3)sc2-c2ccnc(Cl)n2)c1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
KCNH2 Q12809 1/20 0.35
ALDH1A1 P00352 5/20 0.35
ALOX5 P09917 2/20 0.35
AR P10275 3/20 0.35
GAA P10253 3/20 0.34
HPGD P15428 1/20 0.34
PIK3CD O00329 3/20 0.34
PIK3CA P42336 3/20 0.34
PIK3CB P42338 3/20 0.34
PIK3CG P48736 2/20 0.34
EGFR P00533 1/20 0.34
RIPK2 O43353 1/20 0.33
PTGS2 P35354 1/20 0.33
CYP3A4 P08684 1/20 0.33
HTT P42858 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1127552 0.92 KCNH2 (0.37) MEN1KMT2AALOX15HSD17B10KCNH2
SCHEMBL1127292 0.91 KMT2A (0.36) MEN1KMT2AALOX15HSD17B10KCNH2
SCHEMBL1127477 0.83 KCNH2 (0.37) MEN1KMT2AALOX15HSD17B10KCNH2
SCHEMBL1873258 0.83 MEN1 (0.33) MEN1KMT2AALOX15HSD17B10
SCHEMBL1869112 0.80 BRAF (0.37) RIPK2
SCHEMBL12349992 0.80 MEN1 (0.38) MEN1KMT2AKCNH2ALDH1A1GAA
SCHEMBL3889207 0.80 ALDH1A1 (0.41) MEN1KMT2AKCNH2ALDH1A1ALOX5
SCHEMBL1126967 0.78 AR (0.43) ALOX15KCNH2ALDH1A1ARGAA
SCHEMBL2191422 0.78 NR1I2 (0.36) KCNH2EGFR
SCHEMBL12349963 0.76 BRAF (0.38) MEN1KMT2AKCNH2ALDH1A1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160068523-A1 Benzene Sulfonamide Thiazole and Oxazole Compounds NOVARTIS AG (CH) 2016-03-10 US disclosed
US-7994185-B2 Benzene sulfonamide thiazole and oxazole compounds Glaxo Smith Kline LLC (US) 2011-08-09 US disclosed
US-20110172215-A1 Benzene Sulfonamide Thiazole And Oxazole Compounds NOVARTIS AG (CH) 2011-07-14 US disclosed
WO-2011059610-A1 BENZENE SULFONAMIDE THIAZOLE AND OXAZOLE COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-05-19 WO disclosed
EP-2282636-A2 BENZENE SULFONAMIDE THIAZOLE AND OXAZOLE COMPOUNDS GlaxoSmithKline LLC (US) 2011-02-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172215-A1 Benzene Sulfonamide Thiazole And Oxazole Compounds STS, TST, TPST2 MEN1 3639/4885KMT2A 2622/4885ALOX15 3523/4885
US-20160068523-A1 Benzene Sulfonamide Thiazole and Oxazole Compounds STS, TST, TPST2 MEN1 3639/4885KMT2A 2622/4885ALOX15 3523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.